Polymethylmethacrylate efficacy in reduction of renal itching in hemodialysis patients: Crossover study and role of tumor necrosis factor-α

Artificial Organs

Volumn 25, Issue 6, 2001, Pages 441-447

  Kato, Akihiko ^a   Takita, Takato ^b   Furuhashi, Mitsuyoshi ^b   Takahashi, Toshiyuki ^b   Watanabe, Tetsuya ^b   Maruyama, Yukitaka ^b   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruyama Hospital   (Japan)

Author keywords

Hemodialysis; Polymethylmethacrylate; Pruritus; Soluble tumor necrosis factor receptors

Indexed keywords

BODY FLUIDS; DIALYSIS; GLYCOPROTEINS; HEMODIALYZERS; POLYESTERS; POLYMETHYL METHACRYLATES; TUMORS;

% REDUCTIONS; HAEMODIALYSIS; HEMODIALYSIS PATIENT; PROSPECTIVES; PRURITUS; SERUM ALBUMIN; SOLUBLE TUMOR NECROSE FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTORS; TUMOR NECROSIS FACTORS; UNSOLVED PROBLEMS;

MACROPHAGES;

ANTIALLERGIC AGENT; AZELASTINE; EPINASTINE; ERYTHROPOIETIN; POLY(METHYL METHACRYLATE); SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR I; TUMOR NECROSIS FACTOR RECEPTOR II; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIALYSIS MEMBRANE; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PRURITUS; SKIN;

EID: 0034828830     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025006441.x     Document Type: Article

References (26)

1. Uraemic pruritus
2. Histamine and serotonin in uremic pruritus: Effect of ondansetron in CAPD-pruritic patients
3. Uremic pruritus: Roles of parathyroid hormone and substance P
4. Distinct serum cytokines in AIDS-related skin diseases
5. Relief of pain and itch associated with keloids on treatment with oxpentifylline
6. Cytokine expression patterns distinguish HIV associated skin diseases
7. Pruritus in HIV-1 disease: Therapy with drugs which may modulate the pattern of immune dysregulation
8. Efficacy of pentoxifylline in the treatment of pruritic papular eruption of HIV-infected persons
9. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial
10. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients
11. The effects of the dialysis membrane on cytokine release
12. Production of cytokines in hemodialysis
13. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: Evaluation by confocal laser scanning fluorescence microscopy
14. Dialysis efficacy and itching in renal failure
15. Optimal dialysis improves uremic pruritus
16. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo
17. The association between hypoalbuminemia and soluble receptors for tumor necrosis factor (sTNFRs) in patients with hemodialysis
18. High blood soluble receptor for tumor necrosis factor (sTNFR) is associated with erythropoietin (rHuEPO) resistance in hemodialysis (HD) patients
19. A study of pruritus after parathyroidectomy for secondary hyperparathyroidism
20. Role of antigen-induced cytokine release in atopic pruritus
21. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-I gene expression and protein synthesis are independently modulated by hemodialysis membrane
22. 8-Hydroxy-2′-deoxyguanosine of leukocyte as a marker of oxidative stress in chronic hemodialysis patients
23. Case report: Oral antioxidant therapy for the treatment of primary biliary cirrhosis: A pilot study
24. Pruritus and hydration state of stratum corneum in hemodialysis patients
25. Uremic pruritus and skin mast cells
26. Serum bile acids and pruritus in hemodialysis patients